BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/9/2016 9:12:00 AM | Browse: 890 | Download: 1409
Publication Name World Journal of Diabetes
Manuscript ID 28870
Country United States
Received
2016-07-19 09:59
Peer-Review Started
2016-07-21 14:18
To Make the First Decision
2016-09-05 09:12
Return for Revision
2016-09-05 17:00
Revised
Second Decision
2016-09-28 11:27
Accepted by Journal Editor-in-Chief
2016-09-29 10:48
Accepted by Company Editor-in-Chief
2016-10-18 16:35
Articles in Press
2016-10-18 16:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-11-30 10:30
Publish the Manuscript Online
2016-12-09 09:12
ISSN 1948-9358 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Allergy
Manuscript Type Minireviews
Article Title Place of technosphere inhaled insulin in treatment of diabetes
Manuscript Source Invited Manuscript
All Author List Nasser Mikhail
Funding Agency and Grant Number
Corresponding Author Nasser Mikhail, MD, Department of Medicine, OliveView-UCLA Medical Center, 14445 Olive View Dr, Sylmar, CA 91342, United States. nmikhail@dhs.lacounty.gov
Key Words Afrezza; Efficacy; Safety; Technosphere insulin; Cough
Core Tip Technosphere insulin is the only approved form of inhaled insulin. It is a short-acting insulin that can be taken with meals in patients with type 1 or type 2 diabetes. In this minireview, the author provides an appraisal of this new formulation of insulin to help determine its place in the management of diabetes.
Publish Date 2016-12-09 09:12
Citation Mikhail N. Place of technosphere inhaled insulin in treatment of diabetes. World J Diabetes 2016; 7(20): 599-604
URL http://www.wjgnet.com/1948-9358/full/v7/i20/599.htm
DOI http://dx.doi.org/10.4239/wjd.v7.i20.599
Full Article (PDF) WJD-7-599.pdf
Full Article (Word) WJD-7-599.doc
Manuscript File 28870-Review.docx
Answering Reviewers 28870-Answering reviewers.pdf
Audio Core Tip 28870-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 28870-Conflict-of-interest statement.pdf
Copyright License Agreement 28870-Copyright assignment.pdf
Peer-review Report 28870-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 28870-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 28870-Scientific misconduct check.pdf
Scientific Editor Work List 28870-Scientific editor work list.pdf